New health benefits reported for cherries

19 February 2007

The US cherry industry has launched a consumer education campaign and unveiled a paper entitled, The Cherry Nutrition Report, which is the first compendium of peer-reviewed cherry-related studies, and attests to the surprisingly high levels of antioxidants in tart cherries. The report also reviews research that links cherries to a variety of health benefits - from easing the pain of arthritis and gout to potentially offering protection against heart disease and some cancers.

For decades, cherries have quietly grown a devoted fan base of arthritis sufferers who attributed tart cherries, especially tart cherry juice concentrate, to pain relief, according to the Report, which goes on to cite research by Russel Reiter, from the University of Texas Health Science Center in San Antonio, USA, which shows that cherries not only contain significant levels of antioxidants, but also provide a unique combination of antioxidants that are not found in other fruits. Dr Reiter said: "the compounds in cherries act as potent antioxidants that appear to have anti-inflammatory benefits, which may be particularly valuable for aging baby boomers suffering from joint pain."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight